Loading clinical trials...
Loading clinical trials...
Phase II Clinical Trial of Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Patients With Previously Untreated Unresectable Liver-only Metastases From Colorectal Cancer
Conditions
Interventions
Capecitabine
Oxaliplatin
+2 more
Locations
1
United Kingdom
David Cunningham
Sutton, Surrey, United Kingdom
Start Date
June 1, 2006
Primary Completion Date
December 1, 2010
Completion Date
February 1, 2015
Last Updated
November 25, 2015
NCT06625775
NCT04657068
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Royal Marsden NHS Foundation Trust
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions